Macrogen inks license and supply agreement with Thermo Fisher
Kap, Jan. 14 -- Seok Yang, CEO of Macrogen has announced that the company has signed a strategic License and Supply Agreement with Thermo Fisher Scientific. The agreement, which was recently signed, aims to expand the global market for Capillary Electrophoresis Sequencing (CES) service.
Macrogen is a precision medicine and biotechnology company based in South Korea. Thermo Fisher Scientific is a leading bioscience corporation employing more than 70,000 workers globally and earning upwards of $24 billion in annual revenues.
CES, a first-generation base sequence analysis method, accurately reads targeted pieces of genetic data. Recent developments in CES technology have increased the popularity of related applications and the growth rate ...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.